|Dosage and administration||
Hypersensitivity to telmisartan, thiazides and other sulphonamide-derivatives or with any component of the drug.
|Warnings and precautions for use||
|Recommendation for pregnancy and breastfeeding||
|Effects on ability to drive and use machines||
It should be taken into account that dizziness or drowsiness due to hypotension may occasionally occur when taking antihypertensive therapy. Therefore, caution should be taken when driving, using machine or engaging in activities that require complete alertness.
|Interactions, incompatibilities of medicine||
Other antihypertensive agents: The hypotensive effect of Agimstan-H 80/25 may increase when it was co-administered with other antihypertensive agents. Aliskiren and Agimstan-H 80/25 should not be used concomitantly in patients with diabetes or renal failure (Clcr < 60 ml/min).
|Undesirable effects (ADRs)||
|Overdose and management||
There is limited information available for telmisartan with regard to overdose in humans.
Agimstan-H 80/25 is a combination of telmisartan and hydrochlorothiazide which is suitable for once-daily oral administration. The combination of these ingredients has an additive antihypertensive effect to achieve well-controlled blood pressures. Blood pressure is reduced to a greater degree than either component alone.
|Storage conditions, shelf-life, quality specification of the medicine||
Storage conditions: Protect from humidity and light, below 30 degrees C.
Composition: Each tablet contains:
Telmisartan . . . . . . . . . . . . . . . . . . . . . . . 80 mg
Hydrochlorothiazide . . . . . . . . . . . . . . . . . 25 mg
4 blisters of 7 film-coated tablets in a carton box.
Agimstan-H 80/25 fixed dose combination of telmisartan and hydrochlorothiazide is indicated for the treatment of idiopathic hypertension in adults whose blood pressure is not adequately controlled by telmisartan alone or fixed dose combination of telmisartan/hydrochlorothiazide 80/12.5 mg.
Agimstan-H 80/25 is not indicated for initial treatment of hypertension.
If necessary, Agimstan-H 80/25 can be combined with other antihypertensive agent.